Avience Biomedicals Announces SME IPO Date and Pricing Details: Key Information Revealed!

The upcoming IPO for an Indian company is scheduled to open from 18 to 22 June 2026, with a price band set between ₹196 and ₹208. The issue size is estimated at ₹30.24 crore, and the lot size is 600 shares, making the minimum investment for retail investors approximately ₹2,49,600. This private placement will be listed on the NSE SME platform, catering primarily to small and medium enterprises, allowing them to access capital from a wider investment base.

As of now, the grey market sentiment surrounding this IPO remains tentative. While specific indications on grey market premiums have not been disclosed, the vibrancy of small and medium enterprises in the current economic landscape suggests a cautious optimism among potential investors. The price band reflects a balance between attracting investor interest and providing fair valuation, especially as the SME market garners more attention amidst the operational challenges presented in recent years.

For Indian investors, this IPO presents an opportunity to engage with an emerging player in the SME sector, which is increasingly recognized for its potential in driving economic growth. The significant minimum investment amount may limit participation to more affluent retail investors and institutional players, but it shines a spotlight on the growing trend of SMEs seeking public funding to scale operations. Investors should conduct thorough due diligence and consider the risks associated with SME stocks, which can exhibit higher volatility compared to large-cap equities.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)